U.S. Embassy in New Delhi Cracks Down on Fentanyl Trafficking

The U.S. Embassy in New Delhi has taken action against business executives and corporate leadership involved in trafficking fentanyl precursors, revoking and denying visas under the Immigration and Nationality Act.

The U.S. Embassy has denied visas to certain individuals and their close family members, rendering them ineligible for travel to the United States. Executives connected to companies known to have trafficked fentanyl precursors will face heightened scrutiny when applying for U.S. visas.

In a statement , The U.S. Embassy said that Embassy committed to combating illicit drug trafficking, emphasizing that individuals and organizations involved in drug trafficking will face consequences, including denied access to the United States. Chargé d’affaires Jorgan Andrews affirmed, “Stopping the flow of fentanyl, including its precursors, to the United States is one of our top priorities.”

The U.S. government acknowledges the close cooperation of the Government of India in combating this shared challenge. The Trump Administration has taken critical steps to confront the fentanyl crisis through Executive Orders that secure borders, combat drug trafficking organizations, and demand reform from source countries.